{
    "clinical_study": {
        "@rank": "127921", 
        "acronym": "EMISEP", 
        "arm_group": [
            {
                "arm_group_label": "Patients with multiple sclerosis", 
                "arm_group_type": "Experimental", 
                "description": "80 patients / clinical Follow-up at M0, M6, M12, M18, M24, M30, M36, M42, M48, M54 and M60 / spinal cord MRI follow-up at M0, M12, M24, M36 and M60 / brain MRI follow-up at M0, M12, M24, M36 and M60"
            }, 
            {
                "arm_group_label": "Healthy volunteers", 
                "arm_group_type": "Experimental", 
                "description": "20 healthy volunteers (stability of spinal cord imaging) / spinal cord MRI follow-up at M0 and M24"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the prognostic value of early focal lesions and\n      early diffuse lesions on ambulatory disability progression within 5 years after clinical\n      onset."
        }, 
        "brief_title": "EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients", 
        "condition": "Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis", 
                "Multiple Sclerosis, Relapsing-Remitting"
            ]
        }, 
        "detailed_description": {
            "textblock": "Prospective, multicentric study"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Patients with multiple sclerosis:\n\n        Inclusion Criteria:\n\n          -  Relapsing Remitting Multiple Sclerosis patients (Mac Donald 2010 criteria)\n\n          -  First clinical event < 1 year\n\n          -  Brain MRI > 9 lesions or/and spinal cord attack with focal lesion on spinal cord MRI\n\n          -  Score Expended Disability Status Scale < 3\n\n          -  Age between 18 and 40 years\n\n        Exclusion Criteria:\n\n          -  Multiple Sclerosis progressive\n\n          -  Patients treated with immunosuppressive therapy\n\n          -  Pregnancy\n\n        Healthy volunteers:\n\n        Inclusion Criteria:\n\n        -Age between 18 and 40 years\n\n        Exclusion Criteria:\n\n        -Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02117375", 
            "org_study_id": "2013-A00333-42", 
            "secondary_id": "PHRC/12-07"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Patients with multiple sclerosis", 
                    "Healthy volunteers"
                ], 
                "description": "Evaluation : focal lesions (number, volume, localisation), atrophy, parameters from Diffusion Tensor Imaging and parameters from Magnetization Transfer Ratio", 
                "intervention_name": "spinal cord MRI follow-up", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Patients with multiple sclerosis", 
                "description": "Relapses, treatments, global disability,walking performance, upper limbs motor performance, sphincter disturbances and walking difficulty", 
                "intervention_name": "clinical follow-up", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Patients with multiple sclerosis", 
                "intervention_name": "brain MRI follow-up", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "multiple sclerosis", 
            "spinal cord", 
            "MRI", 
            "longitudinal study", 
            "disability"
        ], 
        "lastchanged_date": "April 15, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rennes", 
                    "country": "France"
                }, 
                "name": "CHU Rennes"
            }, 
            "investigator": {
                "last_name": "Gilles GE Edan", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients", 
        "overall_contact": {
            "email": "gilles.edan@chu-rennes.fr", 
            "last_name": "Gilles GE Edan", 
            "phone": "33-2-9928-4122"
        }, 
        "overall_official": [
            {
                "affiliation": "CHU Rennes", 
                "last_name": "Gilles GE Edan", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "CHU Bordeaux", 
                "last_name": "Bruno BB Brochet", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "CHU Dijon", 
                "last_name": "Thibault TM Moreau", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospices civils Lyon", 
                "last_name": "Sandra SV Vukusic", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "AP-HM", 
                "last_name": "Jean JP Pelletier", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "CHU Nancy", 
                "last_name": "Marc MD Debouverie", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Piti\u00e9 Salp\u00eatri\u00e8re", 
                "last_name": "Bruno BS Stankoff", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "CHU Reims", 
                "last_name": "Ayman AT Tourbah", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "CHU Strasbourg", 
                "last_name": "J\u00e9r\u00f4me JD De Seze", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "CHU Toulouse", 
                "last_name": "David DB Brassat", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement by Expended Disability Status Scale", 
            "measure": "Progressive neurological disability", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02117375"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measurement by the 25-foot timed-Walked test and 6 minutes walking", 
                "measure": "Progressive ambulatory disability", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Measurement by the nine-hole peg test", 
                "measure": "Progressive disability in the upper limbs", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Measurement by the questionnaire Qualiveen", 
                "measure": "Progressive urinary disability", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Measurement by the Multiple Sclerosis Walking Scale 12", 
                "measure": "Progressive difficulty walking", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "source": "Rennes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rennes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}